ToxGenSolutions

About:

(Epi-)genetics for preclinical diagnostics and preventative therapeutics for high-impact chronic neurodegenerative and rare pathologies

Website: https://toxgen.solutions

Top Investors: European Union, ToxGenSolutions, Alzheimer's Drug Discovery Foundation, Eurostars, NWO

Description:

(Epi-)genetic approaches addressing molecular initiation events and key events of adverse outcome pathways driving pathologies like neurodegeneration, cancer and immune-dysfunction.

Total Funding Amount:

$1.83M

Headquarters Location:

Maastricht, Limburg, The Netherlands

Founded Date:

2015-05-22

Contact Email:

stan.goertz(AT)toxgen.solutions

Founders:

Erwin Roggen

Number of Employees:

1-10

Last Funding Date:

2023-01-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai